Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Techdow Europe is the European division of Shenzhen Techdow Pharmaceutical, a leading global provider of low molecular weight heparin (LMWH). The company specializes in the development, manufacturing, and commercialization of anticoagulants, most notably Inhixa, a biosimilar enoxaparin sodium. As a subsidiary of the Hepalink Group, Techdow leverages a vertically integrated supply chain to ensure the quality and availability of heparin-based therapies. The company's operations across Europe focus on providing cost-effective solutions for the prevention and treatment of venous thromboembolism and other coagulation-related disorders. Techdow is recognized as one of the largest exporters of enoxaparin from China to the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Techdow Europe.